Published within
|«
«
|
...
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
Patient-based sales forecast for drugs in the Chinese NSCLC market from 2012 to 2021.
Published By Datamonitor
|
12 Dec 2012 |
$11400
|
Report
|
Analysis of Forest's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016
Published By Datamonitor
|
24 Jun 2011 |
$5700
|
Report
|
Overview of the French pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.
Published By Datamonitor
|
17 Dec 2010 |
$11400
|
Report
|
Detailed assessment of two key generic challenges: Eli Lilly's antidepressant Cymbalta (duloxetine) and Celgene's oncology drug Revlimid (lenalidomide).
Published By Datamonitor
|
17 Aug 2012 |
$1900
|
Report
|
Forecast and historical assessment of the generics market from 2005 to 2015
Published By Datamonitor
|
15 Oct 2010 |
$7600
|
Report
|
Datamonitor’s report Generics: Regulatory Update provides an update of changes to generic regulations that occurred in the first half of 2011.
Published By Datamonitor
|
30 Aug 2011 |
$1900
|
Report
|
Insight into changes to generic regulations that occurred during the second half of 2011 and the first half of 2012.
Published By Datamonitor
|
26 Jun 2012 |
$3800
|
Report
|
Analysis of Genzyme's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016
Published By Datamonitor
|
06 May 2011 |
$5700
|
Report
|
Overview of the German pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.
Published By Datamonitor
|
15 Dec 2010 |
$11400
|
Report
|
Analysis of Gilead's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016
Published By Datamonitor
|
20 Oct 2011 |
$5700
|
|«
«
|
...
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.